Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries

Abstract

Diarrheal disease caused by rotavirus claims approximately 500 000 lives each year, mostly in low-income countries. Many of these deaths are preventable through the use of available rotavirus vaccines. Yet, in spite of a WHO recommendation that these vaccines be adopted into all national immunization programs, only a few countries have done so.

Keywords

• Diarrheal disease
• rotavirus
• vaccine